Rasalect 0.5 Tablet Rasagiline (0.5mg)

About this Medicine

Rasalect 0.5 Tablet, containing 0.5mg of Rasagiline, is a prescription medication specifically formulated for the management of Parkinson's disease. This chronic, progressive neurological disorder affects millions, primarily impacting motor control. Rasagiline belongs to a class of drugs known as monoamine oxidase-B (MAO-B) inhibitors. Its mechanism of action involves selectively and irreversibly inhibiting MAO-B enzymes in the brain. These enzymes are responsible for breaking down dopamine, a crucial neurotransmitter vital for smooth, coordinated movement. By inhibiting MAO-B, Rasalect helps to preserve and increase the levels of dopamine in the brain, thereby alleviating some of the debilitating motor symptoms associated with Parkinson's disease. Patients diagnosed with Parkinson's may experience tremors, stiffness (rigidity), slow movement (bradykinesia), and impaired balance. Rasalect 0.5 Tablet can be prescribed as a monotherapy for individuals in the early stages of Parkinson's disease, or as an adjunct therapy alongside levodopa in those with more advanced disease to help manage "off" periods and improve overall motor function. It is important to understand that Rasalect does not cure Parkinson's disease but rather helps to manage its symptoms, contributing to a better quality of life and improved ability to perform daily activities. The decision to prescribe Rasalect, as well as the appropriate dosage, is determined by a healthcare professional based on the individual's condition, medical history, and response to treatment. Close monitoring by a physician is essential to ensure efficacy and manage any potential side effects. Patients should always adhere strictly to their prescribed regimen and never alter their dosage or discontinue the medication without consulting their doctor. A comprehensive discussion with your healthcare provider about all current medications, including over-the-counter drugs and supplements, is crucial to prevent potential drug interactions. This proactive approach ensures the safe and effective use of Rasalect 0.5 Tablet as part of a tailored treatment plan for Parkinson's disease.